Physician profile
Caleb C Johnson
NPI 1720857691
$294.01
in general payments reported to CMS, 2019-2025
10 companies · $131 in 2025
The $131 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $163 · 2025: $131.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $294.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $294.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corium, LLC | $94.52 | 2024-2025 | Azstarys |
| Ironshore Pharmaceuticals INC. | $46.58 | 2024 | |
| Tris Pharma INC | $26.74 | 2025 | Quillivant |
| Biomarin Pharmaceutical INC. | $22.94 | 2025 | Voxzogo 1.2mg |
| Sanofi-Aventis U.S. LLC | $20.78 | 2025 | |
| Acadia Pharmaceuticals INC | $17.86 | 2024 | Daybue |
| Amphastar Pharmaceuticals, INC. | $16.94 | 2024 | Baqsimi |
| Pfizer INC. | $16.45 | 2025 | |
| Collegium Pharmaceutical, INC. | $15.64 | 2025 | Jornay Pm |
| Merck Sharp & Dohme LLC | $15.56 | 2024 | Gardasil, Vaqta, Gardasil 9 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Caleb Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.